151 related articles for article (PubMed ID: 6454771)
1. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone.
Pui CH; Burghen GA; Bowman WP; Aur RJ
J Pediatr; 1981 Jul; 99(1):46-50. PubMed ID: 6454771
[TBL] [Abstract][Full Text] [Related]
2. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
3. Relative hyperglucagonemia in L-asparaginase-and prednisone-induced glucose intolerance in management of acute lymphocytic leukemia.
Turner GR; Marks JF; Buchanan GR
Clin Pediatr (Phila); 1983 May; 22(5):363-7. PubMed ID: 6340906
[TBL] [Abstract][Full Text] [Related]
4. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase.
Dacou-Voutetakis C; Palis J; Haidas S; Zannos-Mariolea L; Georgiopoulou P; Matsaniotis N
Am J Pediatr Hematol Oncol; 1983; 5(2):139-46. PubMed ID: 6351658
[TBL] [Abstract][Full Text] [Related]
5. Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.
Yoshida H; Imamura T; Saito AM; Takahashi Y; Suenobu S; Hasegawa D; Deguchi T; Hashii Y; Kawasaki H; Endo M; Hori H; Suzuki N; Kosaka Y; Kato K; Yumura-Yagi K; Hara J; Oda M; Sato A; Horibe K;
PLoS One; 2015; 10(8):e0136428. PubMed ID: 26317422
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL).
Aisyi M; Andriastuti M; Kurniati N
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2619-2624. PubMed ID: 31554355
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia. A complication of chemotherapy in children.
Walker ED
Cancer Nurs; 1988 Feb; 11(1):18-22. PubMed ID: 3162821
[No Abstract] [Full Text] [Related]
8. Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure.
Aur RJ; Simone JV; Pratt CB
Cancer; 1971 Jun; 27(6):1332-6. PubMed ID: 5282619
[No Abstract] [Full Text] [Related]
9. Nonketotic hyperglycemia due to prednisone (NSC-10023) following ketotic hyperglycemia due to L-asparaginase (NSC-109229) plus prednisone.
Falletta JM; Steuber CP; Hayes JW; Starling KA; Hill LL
Cancer Chemother Rep; 1972 Dec; 56(6):781-2. PubMed ID: 4634039
[No Abstract] [Full Text] [Related]
10. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy.
Weetman RM; Baehner RL
Cancer; 1974 Sep; 34(3):780-5. PubMed ID: 4527863
[No Abstract] [Full Text] [Related]
11. L-asparaginase related hyperglycemia.
Iyer RS; Rao SR; Pai S; Advani SH; Magrath IT
Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dose and schedule of L-asparaginase in multidrug therapy of childhood leukemia.
Sutow WW; George S; Lowman JT; Starling KA; Humphrey GB; Haggard ME; Vietti TJ
Med Pediatr Oncol; 1976; 2(4):387-95. PubMed ID: 1004382
[TBL] [Abstract][Full Text] [Related]
13. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
[TBL] [Abstract][Full Text] [Related]
14. A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia.
Priest JR; Ramsay NK; Steinherz PG; Tubergen DG; Cairo MS; Sitarz AL; Bishop AJ; White L; Trigg ME; Levitt CJ; Cich JA; Coccia PF
J Pediatr; 1982 Jun; 100(6):984-9. PubMed ID: 6953221
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
Lowas SR; Marks D; Malempati S
Pediatr Blood Cancer; 2009 Jul; 52(7):814-8. PubMed ID: 19260096
[TBL] [Abstract][Full Text] [Related]
16. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
Priest JR; Ramsay NK; Bennett AJ; Krivit W; Edson JR
J Pediatr; 1982 Jun; 100(6):990-5. PubMed ID: 6953222
[TBL] [Abstract][Full Text] [Related]
17. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia associated with the therapeutic use of L-asparaginase: possible role of insulin receptors.
Carpentieri U; Balch MT
J Pediatr; 1978 Nov; 93(5):775-8. PubMed ID: 712479
[TBL] [Abstract][Full Text] [Related]
19. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
Kung FH; Nythan WL; Cuttner J; Falkson G; Lanzkowsky P; Del Duca V; Nawabi IU; Koch K; Pluess H; Freeman A; Burgert EO; Leone LA; Ruymann F; Patterson RB; Degnan T; Hakami N; Pajak TF; Holland J
Cancer; 1978 Feb; 41(2):428-34. PubMed ID: 272945
[TBL] [Abstract][Full Text] [Related]
20. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
[No Abstract] [Full Text] [Related]
[Next] [New Search]
